CA2668114C - Fantomes en tissu multicouches, methodes de fabrication et utilisation - Google Patents
Fantomes en tissu multicouches, methodes de fabrication et utilisation Download PDFInfo
- Publication number
- CA2668114C CA2668114C CA2668114A CA2668114A CA2668114C CA 2668114 C CA2668114 C CA 2668114C CA 2668114 A CA2668114 A CA 2668114A CA 2668114 A CA2668114 A CA 2668114A CA 2668114 C CA2668114 C CA 2668114C
- Authority
- CA
- Canada
- Prior art keywords
- phantom
- layer
- layers
- solid feature
- redistributing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 19
- 238000000034 method Methods 0.000 title claims description 115
- 239000000463 material Substances 0.000 claims abstract description 171
- 239000000203 mixture Substances 0.000 claims abstract description 62
- 230000003287 optical effect Effects 0.000 claims abstract description 59
- 238000000151 deposition Methods 0.000 claims abstract description 27
- 230000009969 flowable effect Effects 0.000 claims abstract description 26
- 238000003384 imaging method Methods 0.000 claims abstract description 17
- 238000009826 distribution Methods 0.000 claims abstract description 11
- 239000007787 solid Substances 0.000 claims description 75
- 239000000843 powder Substances 0.000 claims description 43
- 229920001296 polysiloxane Polymers 0.000 claims description 33
- 239000007788 liquid Substances 0.000 claims description 29
- 229920000642 polymer Polymers 0.000 claims description 23
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 claims description 22
- 239000000654 additive Substances 0.000 claims description 21
- 230000033001 locomotion Effects 0.000 claims description 21
- 239000006229 carbon black Substances 0.000 claims description 20
- 230000008569 process Effects 0.000 claims description 18
- 229920005989 resin Polymers 0.000 claims description 18
- 239000011347 resin Substances 0.000 claims description 18
- 230000000149 penetrating effect Effects 0.000 claims description 17
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 claims description 17
- 239000012530 fluid Substances 0.000 claims description 16
- 238000010438 heat treatment Methods 0.000 claims description 12
- 230000005484 gravity Effects 0.000 claims description 10
- 230000001575 pathological effect Effects 0.000 claims description 9
- 241001465754 Metazoa Species 0.000 claims description 8
- 239000002952 polymeric resin Substances 0.000 claims description 8
- 229920003002 synthetic resin Polymers 0.000 claims description 8
- 230000000996 additive effect Effects 0.000 claims description 7
- 150000001875 compounds Chemical class 0.000 claims description 7
- 239000011800 void material Substances 0.000 claims description 7
- 230000009471 action Effects 0.000 claims description 6
- 229920001971 elastomer Polymers 0.000 claims description 6
- 210000000056 organ Anatomy 0.000 claims description 6
- 238000012360 testing method Methods 0.000 claims description 6
- 238000012549 training Methods 0.000 claims description 6
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 claims description 5
- 238000012634 optical imaging Methods 0.000 claims description 5
- 230000035515 penetration Effects 0.000 claims description 5
- 230000002159 abnormal effect Effects 0.000 claims description 4
- 230000001747 exhibiting effect Effects 0.000 claims description 4
- 239000007943 implant Substances 0.000 claims description 4
- 239000002904 solvent Substances 0.000 claims description 3
- 238000001228 spectrum Methods 0.000 claims description 3
- 238000005507 spraying Methods 0.000 claims description 3
- 238000012014 optical coherence tomography Methods 0.000 abstract description 28
- 230000003278 mimic effect Effects 0.000 abstract description 21
- 210000001519 tissue Anatomy 0.000 description 63
- 210000004351 coronary vessel Anatomy 0.000 description 20
- 230000006870 function Effects 0.000 description 19
- 230000004044 response Effects 0.000 description 19
- 239000011159 matrix material Substances 0.000 description 18
- 230000008021 deposition Effects 0.000 description 13
- 210000004204 blood vessel Anatomy 0.000 description 11
- 210000002808 connective tissue Anatomy 0.000 description 11
- 238000009472 formulation Methods 0.000 description 10
- 239000000523 sample Substances 0.000 description 10
- 238000007493 shaping process Methods 0.000 description 10
- 238000005259 measurement Methods 0.000 description 9
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 9
- 210000001367 artery Anatomy 0.000 description 8
- 239000011344 liquid material Substances 0.000 description 7
- 238000002156 mixing Methods 0.000 description 7
- 239000011343 solid material Substances 0.000 description 6
- 238000007711 solidification Methods 0.000 description 6
- 230000008023 solidification Effects 0.000 description 6
- 238000013519 translation Methods 0.000 description 6
- 230000015572 biosynthetic process Effects 0.000 description 5
- 239000008280 blood Substances 0.000 description 5
- 210000004369 blood Anatomy 0.000 description 5
- 238000000465 moulding Methods 0.000 description 5
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- 238000010521 absorption reaction Methods 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- 239000003638 chemical reducing agent Substances 0.000 description 3
- 238000000576 coating method Methods 0.000 description 3
- 230000001419 dependent effect Effects 0.000 description 3
- 238000003892 spreading Methods 0.000 description 3
- 230000007480 spreading Effects 0.000 description 3
- 238000001356 surgical procedure Methods 0.000 description 3
- 201000001320 Atherosclerosis Diseases 0.000 description 2
- 206010072810 Vascular wall hypertrophy Diseases 0.000 description 2
- 238000002399 angioplasty Methods 0.000 description 2
- 230000002308 calcification Effects 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 238000012512 characterization method Methods 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- 238000012937 correction Methods 0.000 description 2
- 239000013078 crystal Substances 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 239000013013 elastic material Substances 0.000 description 2
- 239000000806 elastomer Substances 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 230000008020 evaporation Effects 0.000 description 2
- 238000001704 evaporation Methods 0.000 description 2
- 239000010419 fine particle Substances 0.000 description 2
- 238000011010 flushing procedure Methods 0.000 description 2
- 230000003902 lesion Effects 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 230000008018 melting Effects 0.000 description 2
- 238000002844 melting Methods 0.000 description 2
- TWNQGVIAIRXVLR-UHFFFAOYSA-N oxo(oxoalumanyloxy)alumane Chemical compound O=[Al]O[Al]=O TWNQGVIAIRXVLR-UHFFFAOYSA-N 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 230000007170 pathology Effects 0.000 description 2
- 239000000049 pigment Substances 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 229920002050 silicone resin Polymers 0.000 description 2
- 210000004872 soft tissue Anatomy 0.000 description 2
- 229920001169 thermoplastic Polymers 0.000 description 2
- 239000004416 thermosoftening plastic Substances 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 238000005303 weighing Methods 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 241000721047 Danaus plexippus Species 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 239000011358 absorbing material Substances 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000003466 anti-cipated effect Effects 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 210000000621 bronchi Anatomy 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 159000000007 calcium salts Chemical class 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 230000001427 coherent effect Effects 0.000 description 1
- 210000001072 colon Anatomy 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 239000000428 dust Substances 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 238000001839 endoscopy Methods 0.000 description 1
- 239000003822 epoxy resin Substances 0.000 description 1
- 210000003238 esophagus Anatomy 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- LNEPOXFFQSENCJ-UHFFFAOYSA-N haloperidol Chemical compound C1CC(O)(C=2C=CC(Cl)=CC=2)CCN1CCCC(=O)C1=CC=C(F)C=C1 LNEPOXFFQSENCJ-UHFFFAOYSA-N 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 239000001023 inorganic pigment Substances 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 230000004807 localization Effects 0.000 description 1
- 238000003754 machining Methods 0.000 description 1
- 229910044991 metal oxide Inorganic materials 0.000 description 1
- 150000004706 metal oxides Chemical class 0.000 description 1
- 238000001000 micrograph Methods 0.000 description 1
- 210000003470 mitochondria Anatomy 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 230000000877 morphologic effect Effects 0.000 description 1
- 230000001338 necrotic effect Effects 0.000 description 1
- 210000004940 nucleus Anatomy 0.000 description 1
- 239000013307 optical fiber Substances 0.000 description 1
- 239000003973 paint Substances 0.000 description 1
- -1 poly(vinyl alcohol) Polymers 0.000 description 1
- 229920000647 polyepoxide Polymers 0.000 description 1
- 229920000728 polyester Polymers 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 230000000135 prohibitive effect Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 238000005086 pumping Methods 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 231100000241 scar Toxicity 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 238000000527 sonication Methods 0.000 description 1
- 230000003068 static effect Effects 0.000 description 1
- 230000001360 synchronised effect Effects 0.000 description 1
- 230000008685 targeting Effects 0.000 description 1
- 238000012345 traction test Methods 0.000 description 1
- 238000009827 uniform distribution Methods 0.000 description 1
- 229940054870 urso Drugs 0.000 description 1
- RUDATBOHQWOJDD-UZVSRGJWSA-N ursodeoxycholic acid Chemical compound C([C@H]1C[C@@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(O)=O)C)[C@@]2(C)CC1 RUDATBOHQWOJDD-UZVSRGJWSA-N 0.000 description 1
- 230000008016 vaporization Effects 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J7/00—Chemical treatment or coating of shaped articles made of macromolecular substances
- C08J7/04—Coating
- C08J7/042—Coating with two or more layers, where at least one layer of a composition contains a polymer binder
-
- G—PHYSICS
- G09—EDUCATION; CRYPTOGRAPHY; DISPLAY; ADVERTISING; SEALS
- G09B—EDUCATIONAL OR DEMONSTRATION APPLIANCES; APPLIANCES FOR TEACHING, OR COMMUNICATING WITH, THE BLIND, DEAF OR MUTE; MODELS; PLANETARIA; GLOBES; MAPS; DIAGRAMS
- G09B23/00—Models for scientific, medical, or mathematical purposes, e.g. full-sized devices for demonstration purposes
- G09B23/28—Models for scientific, medical, or mathematical purposes, e.g. full-sized devices for demonstration purposes for medicine
- G09B23/30—Anatomical models
Landscapes
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Physics & Mathematics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Polymers & Plastics (AREA)
- Organic Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Algebra (AREA)
- Medical Informatics (AREA)
- Computational Mathematics (AREA)
- General Health & Medical Sciences (AREA)
- Mathematical Analysis (AREA)
- Mathematical Optimization (AREA)
- Mathematical Physics (AREA)
- Pure & Applied Mathematics (AREA)
- Business, Economics & Management (AREA)
- Educational Administration (AREA)
- Educational Technology (AREA)
- Theoretical Computer Science (AREA)
- Prostheses (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CA2668114A CA2668114C (fr) | 2009-06-02 | 2009-06-02 | Fantomes en tissu multicouches, methodes de fabrication et utilisation |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CA2668114A CA2668114C (fr) | 2009-06-02 | 2009-06-02 | Fantomes en tissu multicouches, methodes de fabrication et utilisation |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CA2668114A1 CA2668114A1 (fr) | 2010-12-02 |
| CA2668114C true CA2668114C (fr) | 2017-11-28 |
Family
ID=43298692
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA2668114A Expired - Fee Related CA2668114C (fr) | 2009-06-02 | 2009-06-02 | Fantomes en tissu multicouches, methodes de fabrication et utilisation |
Country Status (1)
| Country | Link |
|---|---|
| CA (1) | CA2668114C (fr) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113781880B (zh) * | 2021-06-28 | 2022-11-11 | 中山大学 | 一种动脉粥样硬化斑块模型的制备方法 |
-
2009
- 2009-06-02 CA CA2668114A patent/CA2668114C/fr not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CA2668114A1 (fr) | 2010-12-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US9588042B2 (en) | Multilayered tissue phantoms, fabrication methods, and use | |
| Lamouche et al. | Review of tissue simulating phantoms with controllable optical, mechanical and structural properties for use in optical coherence tomography | |
| Singh et al. | Investigating elastic anisotropy of the porcine cornea as a function of intraocular pressure with optical coherence elastography | |
| EP2478514B1 (fr) | Fantôme d'organe bimodal et méthode de production associée | |
| CN100502808C (zh) | 用于关节表面再造的组合物 | |
| US20200316850A1 (en) | Anatomical silicon models and additive manufacturing thereof | |
| US20110230964A1 (en) | Prosthetic implant shell | |
| JP2011209691A (ja) | 光音響整合材及び人体組織模擬材料 | |
| JP2010513977A (ja) | 解剖学的及び機能的に正確な軟組織ファントム並びにその製造方法 | |
| In et al. | Novel development of 3D printable UV-curable silicone for multimodal imaging phantom | |
| KR101725094B1 (ko) | 다층 광 팬텀 및 그 제조방법 | |
| CA2668114C (fr) | Fantomes en tissu multicouches, methodes de fabrication et utilisation | |
| Tejo-Otero et al. | Soft-tissue-mimicking using silicones for the manufacturing of soft phantoms by fresh 3D printing | |
| Aryeetey et al. | Development of 3D printed tissue-mimicking materials: Combining fiber reinforcement and fluid content for improved surgical rehearsal | |
| Bisaillon et al. | Artery phantoms for intravascular optical coherence tomography: diseased arteries | |
| Bisaillon et al. | Durable coronary artery phantoms for optical coherence tomography | |
| Linde et al. | 3D printed human skull phantoms for transcranial photoacoustic imaging | |
| Grasso et al. | Development of a morphologically realistic mouse phantom for pre‐clinical photoacoustic imaging | |
| RU2682459C1 (ru) | Способ формирования фантомов кровеносных сосудов для эндоскопической оптической когерентной эластографии | |
| Chen et al. | Application of ultrasound on monitoring the evolution of the collagen fiber reinforced nHAC/CS composites in vivo | |
| Bisaillon et al. | Durable optical phantoms with complex geometries and tissue-like mechanical properties | |
| Bohndiek et al. | Stable phantoms for characterization of photoacoustic tomography (PAT) systems | |
| Bodian | Fabrication of Composite Materials for Medical Imaging and Device Characterisation | |
| Brace et al. | Segmental airway adenocarcinoma-simulating phantom for endoscopic near-infrared optical coherence tomography | |
| KR20240155346A (ko) | 초음파촬영 및 방사선학적 영상화의 개선을 위한 의료 디바이스용 레이저-적용 마킹 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request |
Effective date: 20140529 |
|
| MKLA | Lapsed |
Effective date: 20190603 |